These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 15521431

  • 21. FDA seeks to clear up confusion about compounding.
    J Am Vet Med Assoc; 2003 Oct 15; 223(8):1103, 1106. PubMed ID: 14584731
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. New law gives FDA more influence to monitor drug safety.
    Wadman M.
    Nat Med; 2007 Nov 15; 13(11):1269. PubMed ID: 17987008
    [No Abstract] [Full Text] [Related]

  • 24. Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics.
    Mealey KL.
    Vet Parasitol; 2008 Dec 10; 158(3):215-22. PubMed ID: 18922637
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. FDA bans firms from importing and distributing contaminated animal drugs.
    J Am Vet Med Assoc; 1999 May 15; 214(10):1459. PubMed ID: 10340065
    [No Abstract] [Full Text] [Related]

  • 27. Preventive chemotherapy of canine dirofilariasis with diethylcarbamazine. SAM-TR-68-95.
    Tulloch GS, Pacheco G, Casey HW, Bills WE.
    Tech Rep SAM-TR; 1968 Aug 15; ():1-13. PubMed ID: 5303692
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. FDA marketing claims, and the practitioner.
    Runner S.
    J Evid Based Dent Pract; 2006 Mar 15; 6(1):19-23. PubMed ID: 17138391
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. US FDA contemplates collection of pharmacogenomic data.
    Kling J.
    Nat Biotechnol; 2003 Jun 15; 21(6):590. PubMed ID: 12776133
    [No Abstract] [Full Text] [Related]

  • 34. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL.
    J Natl Cancer Inst; 2005 Jun 15; 97(12):872-3. PubMed ID: 15956645
    [No Abstract] [Full Text] [Related]

  • 35. Opening Pandora's pillbox: using modern information tools to improve drug safety.
    Gottlieb S.
    Health Aff (Millwood); 2005 Jun 15; 24(4):938-48. PubMed ID: 16012136
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The FDA and new safety warnings.
    Moore TJ, Singh S, Furberg CD.
    Arch Intern Med; 2012 Jan 09; 172(1):78-80. PubMed ID: 22232155
    [No Abstract] [Full Text] [Related]

  • 39. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C, Bowsher K, Costello A, De Luca R, Doll S, Li K, Schroeder M, Stevens T.
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep 09; 15(3):421-4. PubMed ID: 17894274
    [Abstract] [Full Text] [Related]

  • 40. Canine and feline dirofilariasis.
    Murray MJ.
    Compend Contin Educ Vet; 2008 Aug 09; 30(8):442-3, 456; author reply 456-7. PubMed ID: 19086252
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.